Vista LifeSciences

Vista LifeSciences (VLS) develops mobile health technology and cognitive assessment software for use across a wide range of care settings, including hospitals, clinics, rural and remote environments, telemedicine platforms, and public health programs. The company serves a global client base and states that its products have been used in nearly five million patient encounters worldwide.

VLS describes its mission as improving health and supporting care providers globally through solutions designed for early intervention and longitudinal patient care. The company draws on clinical research and expertise to produce scalable, easy-to-use tools suited to both well-resourced and underserved populations.

Key Products

• ANAM (Automated Neuropsychological Assessment Metrics): FDA-cleared cognitive and behavioral health assessments designed for use in patient and clinical encounters.
• UltraMobile: Software deployed on mobile devices for use during patient or client encounters. It includes disease- and health-condition-specific clinical pathways as well as ANAM cognitive and behavioral health assessments.
• Data, Analytics, and AI: Mobile and cloud-based tools supporting patient management and population health monitoring.

Core Capabilities

• Process improvement consulting, working with clients to design and integrate solutions for care delivery.
• Longitudinal health assessments and disease management systems for both personal and community health management.
• Deployment across diverse environments, including urban, rural, remote, and rugged locations, as well as telemedicine settings.
• Customisation of solutions in partnership with clients, and integration with third-party colleagues and systems.

Research and Reach

• VLS maintains a body of research and publications covering sports-related applications and test validation for its assessment tools.
• The company operates on every continent and positions its solutions for use in both high-resource and underserved global settings.
• Sustainable, scalable solutions are a stated focus, particularly for populations with limited access to traditional healthcare infrastructure.

Vista LifeSciences combines its mHealth platform and FDA-cleared cognitive assessment tools with a partnership-oriented delivery model, serving clients across healthcare, public health, and community care contexts globally.